These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31729757)

  • 1. Seizures of Clandestinely Produced Tablets in Santa Catarina, Brazil: The Increase in NPS from 2011 to 2017.
    de Souza Júnior JL; Silveira Filho J; Boff BS; Nonemacher K; Rezin KZ; Schroeder SD; Ferrão MF; Danielli LJ
    J Forensic Sci; 2020 May; 65(3):906-912. PubMed ID: 31729757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical composition of Ecstasy tablets seized in Poland between 2005 and 2020.
    Byrska B; Stanaszek R
    Forensic Toxicol; 2024 Jul; ():. PubMed ID: 39017813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of New Psychoactive Substances (NPS) in northeast Brazil: NMR-based identification and analysis of ecstasy tablets by GC-MS.
    Cunha RL; Oliveira CDSL; de Oliveira AL; Maldaner AO; do Desterro Cunha S; Pereira PAP
    Forensic Sci Int; 2023 Mar; 344():111597. PubMed ID: 36801502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The variability of ecstasy tablets composition in Brazil.
    Togni LR; Lanaro R; Resende RR; Costa JL
    J Forensic Sci; 2015 Jan; 60(1):147-51. PubMed ID: 25125149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New psychoactive substances (NPS) prevalence over LSD in blotter seized in State of Santa Catarina, Brazil: A six-year retrospective study.
    de Souza Boff B; Silveira Filho J; Nonemacher K; Driessen Schroeder S; Dutra Arbo M; Rezin KZ
    Forensic Sci Int; 2020 Jan; 306():110002. PubMed ID: 31864775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of 1-benzylpiperazine, 1-(3-trifluoromethylphenyl)-piperazine, and 1-(3-chlorophenyl)-piperazine in 3,4-methylenedioxymethamphetamine-positive urine samples.
    Dickson AJ; Vorce SP; Holler JM; Lyons TP
    J Anal Toxicol; 2010 Oct; 34(8):464-9. PubMed ID: 21819791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening method for rapid classification of psychoactive substances in illicit tablets using mid infrared spectroscopy and PLS-DA.
    Pereira LSA; Lisboa FLC; Coelho Neto J; Valladão FN; Sena MM
    Forensic Sci Int; 2018 Jul; 288():227-235. PubMed ID: 29777946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A snapshot on NPS in Italy: Distribution of drugs in seized materials analysed in an Italian forensic laboratory in the period 2013-2015.
    Odoardi S; Romolo FS; Strano-Rossi S
    Forensic Sci Int; 2016 Aug; 265():116-20. PubMed ID: 26874736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Life expectancy" of "ecstasy" tablets in Israel in the years 2001-2003.
    Levy R; Zelkowicz A; Abu E; Ravreby MD
    Forensic Sci Int; 2007 Mar; 167(1):22-9. PubMed ID: 16870373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability in the 3,4-methylenedioxymethamphetamine content of 'ecstasy' tablets in the UK.
    Wood DM; Stribley V; Dargan PI; Davies S; Holt DW; Ramsey J
    Emerg Med J; 2011 Sep; 28(9):764-5. PubMed ID: 20724467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The content of ecstasy tablets: implications for the study of their long-term effects.
    Cole JC; Bailey M; Sumnall HR; Wagstaff GF; King LA
    Addiction; 2002 Dec; 97(12):1531-6. PubMed ID: 12472637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical profiling of 3,4-methylenedioxymethamphetamine (MDMA) tablets seized in Hong Kong.
    Cheng WC; Poon NL; Chan MF
    J Forensic Sci; 2003 Nov; 48(6):1249-59. PubMed ID: 14640267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of ecstasy tablets seized in iran.
    Khajeamiri AR; Kobarfard F; Ahmadkhaniha R; Mostashari G
    Iran J Pharm Res; 2011; 10(2):211-20. PubMed ID: 24250345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Content of ecstasy in the Netherlands: 1993-2008.
    Vogels N; Brunt TM; Rigter S; van Dijk P; Vervaeke H; Niesink RJ
    Addiction; 2009 Dec; 104(12):2057-66. PubMed ID: 19804461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining attenuated total reflectance- infrared spectroscopy and chemometrics for the identification and the dosage estimation of MDMA tablets.
    Deconinck E; Van Campenhout R; Aouadi C; Canfyn M; Bothy JL; Gremeaux L; Blanckaert P; Courselle P
    Talanta; 2019 Apr; 195():142-151. PubMed ID: 30625524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Library Search-Based Screening System for 3,4-Methylenedioxymethamphetamine in Ecstasy Tablets Using a Portable Near-Infrared Spectrometer.
    Tsujikawa K; Yamamuro T; Kuwayama K; Kanamori T; Iwata YT; Miyamoto K; Kasuya F; Inoue H
    J Forensic Sci; 2016 Sep; 61(5):1208-14. PubMed ID: 27362667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and trends of 3,4-methylenedioxymethamphetamine (MDMA) tablets found in Taiwan from 2002 to February 2005.
    Teng SF; Wu SC; Liu C; Li JH; Chien CS
    Forensic Sci Int; 2006 Sep; 161(2-3):202-8. PubMed ID: 16842946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A quantitative analysis of MDMA seized at New South Wales music festivals over the 2019/2020 season: Form, purity, dose and adulterants.
    O'Reilly MJA; Harvey CA; Auld R; Cretikos M; Francis C; Todd S; Barry D; Cullinan U; Symonds M
    Drug Alcohol Rev; 2022 Feb; 41(2):330-337. PubMed ID: 34919770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Composition profiling of seized ecstasy tablets by Raman spectroscopy.
    Bell SE; Burns DT; Dennis AC; Matchett LJ; Speers JS
    Analyst; 2000 Oct; 125(10):1811-5. PubMed ID: 11070550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impurity profiling of ecstasy tablets seized in Hong Kong by gas chromatography-mass spectrometry.
    Cheng JY; Chan MF; Chan TW; Hung MY
    Forensic Sci Int; 2006 Oct; 162(1-3):87-94. PubMed ID: 16860955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.